Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds.

Tian X, Werner ME, Roche KC, Hanson AD, Foote HP, Yu SK, Warner SB, Copp JA, Lara H, Wauthier EL, Caster JM, Herring LE, Zhang L, Tepper JE, Hsu DS, Zhang T, Reid LM, Wang AZ.

Nat Biomed Eng. 2018;2:443-452. Epub 2018 Apr 23.

2.

Fluorescent fusions of the N protein of phage Mu label DNA damage in living cells.

Kotlajich MV, Xia J, Zhai Y, Lin HY, Bradley CC, Shen X, Mei Q, Wang AZ, Lynn EJ, Shee C, Chen LT, Li L, Miller KM, Herman C, Hastings PJ, Rosenberg SM.

DNA Repair (Amst). 2018 Sep 14. pii: S1568-7864(18)30095-8. doi: 10.1016/j.dnarep.2018.09.005. [Epub ahead of print]

3.

Advancing the Pharmaceutical Potential of Bioinorganic Hybrid Lipid-Based Assemblies.

Wang J, Wang AZ, Lv P, Tao W, Liu G.

Adv Sci (Weinh). 2018 Jul 20;5(9):1800564. doi: 10.1002/advs.201800564. eCollection 2018 Sep. Review.

4.

Ultrasound-guided posterior ramus of spinal nerve block for anesthesia and analgesia in lumbar spinal surgery.

Wang AZ, Fan K.

J Clin Anesth. 2018 Aug 31;52:48-49. doi: 10.1016/j.jclinane.2018.08.032. [Epub ahead of print] No abstract available.

PMID:
30176503
5.

RUNX1 upregulation via disruption of long-range transcriptional control by a novel t(5;21)(q13;q22) translocation in acute myeloid leukemia.

Cheng CK, Wong THY, Wan TSK, Wang AZ, Chan NPH, Chan NCN, Li CK, Ng MHL.

Mol Cancer. 2018 Aug 29;17(1):133. doi: 10.1186/s12943-018-0881-2.

6.

A lateral approach to ultrasound-guided sacral plexus block in the supine position.

Wang AZ, Fan K, Zhou QH, Wang C, Niu Q, Chan Y.

Anaesthesia. 2018 Aug;73(8):1043-1044. doi: 10.1111/anae.14368. No abstract available.

PMID:
30117581
7.

Cardiovascular Preventive Care and Coordination Of Care In Prostate Cancer Survivors: A Multi-Institutional Prospective Study.

Holmes JA, Anderson RF, Hoffman LG, Showalter TN, Kasibhatla M, Collins SP, Papagikos MA, Barbosa BD, Stravers LJ, Mahbooba Z, Wang AZ, Chen RC.

Int J Radiat Oncol Biol Phys. 2018 Aug 9. pii: S0360-3016(18)33519-3. doi: 10.1016/j.ijrobp.2018.07.2018. [Epub ahead of print]

PMID:
30099132
8.

Nanotechnology Approaches to Improving Cancer Immunotherapy.

Hagan CT 4th, Medik YB, Wang AZ.

Adv Cancer Res. 2018;139:35-56. doi: 10.1016/bs.acr.2018.05.003. Epub 2018 Jun 7.

PMID:
29941106
9.

Ultrasound-guided multiple nerve block with a small volume local anesthetic at each site for radical mastectomy in day surgery.

Wang AZ, Fan K, Niu Q.

J Clin Anesth. 2018 Sep;49:44-45. doi: 10.1016/j.jclinane.2018.06.008. Epub 2018 Jun 7. No abstract available.

PMID:
29886269
10.

Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers.

Hong S, Wang AZ.

Adv Drug Deliv Rev. 2018 Feb 1;125:1-2. doi: 10.1016/j.addr.2018.04.014. No abstract available.

PMID:
29880212
11.

A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy.

Mi Y, Smith CC, Yang F, Qi Y, Roche KC, Serody JS, Vincent BG, Wang AZ.

Adv Mater. 2018 Jun;30(25):e1706098. doi: 10.1002/adma.201706098. Epub 2018 Apr 25.

PMID:
29691900
12.

Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models.

Zhang M, Hagan CT 4th, Min Y, Foley H, Tian X, Yang F, Mi Y, Au KM, Medik Y, Roche K, Wagner K, Rodgers Z, Wang AZ.

Biomaterials. 2018 Jul;169:1-10. doi: 10.1016/j.biomaterials.2018.03.055. Epub 2018 Mar 31.

PMID:
29631163
13.

Clinical indications for, and the future of, circulating tumor cells.

Moon DH, Lindsay DP, Hong S, Wang AZ.

Adv Drug Deliv Rev. 2018 Feb 1;125:143-150. doi: 10.1016/j.addr.2018.04.002. Epub 2018 Apr 5. Review.

PMID:
29626548
14.

Controlling release from 3D printed medical devices using CLIP and drug-loaded liquid resins.

Bloomquist CJ, Mecham MB, Paradzinsky MD, Janusziewicz R, Warner SB, Luft JC, Mecham SJ, Wang AZ, DeSimone JM.

J Control Release. 2018 May 28;278:9-23. doi: 10.1016/j.jconrel.2018.03.026. Epub 2018 Mar 27.

PMID:
29596874
15.

Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture.

Myung JH, Eblan MJ, Caster JM, Park SJ, Poellmann MJ, Wang K, Tam KA, Miller SM, Shen C, Chen RC, Zhang T, Tepper JE, Chera BS, Wang AZ, Hong S.

Clin Cancer Res. 2018 Jun 1;24(11):2539-2547. doi: 10.1158/1078-0432.CCR-17-3078. Epub 2018 Mar 15.

PMID:
29545463
16.

Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer.

Wan X, Min Y, Bludau H, Keith A, Sheiko SS, Jordan R, Wang AZ, Sokolsky-Papkov M, Kabanov AV.

ACS Nano. 2018 Mar 27;12(3):2426-2439. doi: 10.1021/acsnano.7b07878. Epub 2018 Mar 16.

17.

Energetic costs of performance in trained and untrained Anolis carolinensis lizards.

Lailvaux SP, Wang AZ, Husak JF.

J Exp Biol. 2018 Apr 23;221(Pt 8). pii: jeb176867. doi: 10.1242/jeb.176867.

18.

Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy.

Mavroidis P, Pearlstein KA, Dooley J, Sun J, Saripalli S, Das SK, Wang AZ, Chen RC.

Radiat Oncol. 2018 Feb 2;13(1):17. doi: 10.1186/s13014-018-0961-x.

19.

A prospective study of the safety and efficacy of liver stereotactic body radiotherapy in patients with and without prior liver-directed therapy.

Moon DH, Wang AZ, Tepper JE.

Radiother Oncol. 2018 Mar;126(3):527-533. doi: 10.1016/j.radonc.2018.01.004. Epub 2018 Jan 30.

PMID:
29366521
20.

Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma.

Au KM, Tripathy A, Lin CP, Wagner K, Hong S, Wang AZ, Park SI.

ACS Nano. 2018 Feb 27;12(2):1544-1563. doi: 10.1021/acsnano.7b08122. Epub 2018 Jan 26.

PMID:
29361211
21.

Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.

Hartshorn CM, Bradbury MS, Lanza GM, Nel AE, Rao J, Wang AZ, Wiesner UB, Yang L, Grodzinski P.

ACS Nano. 2018 Jan 23;12(1):24-43. doi: 10.1021/acsnano.7b05108. Epub 2017 Dec 22.

PMID:
29257865
22.

Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs).

Myung JH, Park SJ, Wang AZ, Hong S.

Adv Drug Deliv Rev. 2018 Feb 1;125:36-47. doi: 10.1016/j.addr.2017.12.005. Epub 2017 Dec 13. Review.

PMID:
29247765
23.

Mapping and comparative proteomic analysis of the starch biosynthetic pathway in rice by 2D PAGE/MS.

Chang TS, Liu CW, Lin YL, Li CY, Wang AZ, Chien MW, Wang CS, Lai CC.

Plant Mol Biol. 2017 Nov;95(4-5):333-343. doi: 10.1007/s11103-017-0652-2. Epub 2017 Sep 8.

PMID:
28887709
24.

Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models.

Tian J, Min Y, Rodgers Z, Au KM, Hagan CT 4th, Zhang M, Roche K, Yang F, Wagner K, Wang AZ.

J Mater Chem B. 2017 Aug 14;5(30):6049-6057. doi: 10.1039/C7TB01370A. Epub 2017 Jul 5.

25.

Applying nanotherapeutics to improve chemoradiotherapy treatment for cancer.

Caster JM, Wang AZ.

Ther Deliv. 2017 Aug;8(9):791-803. doi: 10.4155/tde-2017-0043. Review.

PMID:
28825397
26.

Rac2 deficiency attenuates CCl4-induced liver injury through suppressing inflammation and oxidative stress.

Zou Y, Xiong JB, Ma K, Wang AZ, Qian KJ.

Biomed Pharmacother. 2017 Oct;94:140-149. doi: 10.1016/j.biopha.2017.07.074. Epub 2017 Jul 28.

PMID:
28759751
27.

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy.

Min Y, Roche KC, Tian S, Eblan MJ, McKinnon KP, Caster JM, Chai S, Herring LE, Zhang L, Zhang T, DeSimone JM, Tepper JE, Vincent BG, Serody JS, Wang AZ.

Nat Nanotechnol. 2017 Sep;12(9):877-882. doi: 10.1038/nnano.2017.113. Epub 2017 Jun 26.

28.

Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody.

Wang C, Sun W, Wright G, Wang AZ, Gu Z.

Adv Mater. 2017 Apr;29(15). doi: 10.1002/adma.201700761. No abstract available.

PMID:
28407370
29.

FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia.

Cheng CK, Wang AZ, Wong THY, Wan TSK, Cheung JS, Raghupathy R, Chan NPH, Ng MHL.

Blood. 2017 May 11;129(19):2705-2709. doi: 10.1182/blood-2017-02-767707. Epub 2017 Mar 17. No abstract available.

30.

Effect of particle size on the biodistribution, toxicity, and efficacy of drug-loaded polymeric nanoparticles in chemoradiotherapy.

Caster JM, Yu SK, Patel AN, Newman NJ, Lee ZJ, Warner SB, Wagner KT, Roche KC, Tian X, Min Y, Wang AZ.

Nanomedicine. 2017 Jul;13(5):1673-1683. doi: 10.1016/j.nano.2017.03.002. Epub 2017 Mar 11.

31.

Nanoparticle-Delivered Chemotherapy: Old Drugs in New Packages.

Lee MS, Dees EC, Wang AZ.

Oncology (Williston Park). 2017 Mar 15;31(3):198-208. Review.

32.

Nanomedicine approaches to improve cancer immunotherapy.

Qiu H, Min Y, Rodgers Z, Zhang L, Wang AZ.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Sep;9(5). doi: 10.1002/wnan.1456. Epub 2017 Mar 10. Review.

33.

Patient-reported quality of life during definitive and postprostatectomy image-guided radiation therapy for prostate cancer.

Diao K, Lobos EA, Yirmibesoglu E, Basak R, Hendrix LH, Barbosa B, Miller SM, Pearlstein KA, Goldin GH, Wang AZ, Chen RC.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):e117-e124. doi: 10.1016/j.prro.2016.08.004. Epub 2016 Aug 12.

PMID:
28274402
34.

Application of nanotechnology to cancer radiotherapy.

Mi Y, Shao Z, Vang J, Kaidar-Person O, Wang AZ.

Cancer Nanotechnol. 2016;7(1):11. doi: 10.1186/s12645-016-0024-7. Epub 2016 Dec 19. Review.

35.

Bio-nano interface: The impact of biological environment on nanomaterials and their delivery properties.

Cai K, Wang AZ, Yin L, Cheng J.

J Control Release. 2017 Oct 10;263:211-222. doi: 10.1016/j.jconrel.2016.11.034. Epub 2017 Jan 3. Review.

PMID:
28062299
36.

Poor Consumer Comprehension and Plan Selection Inconsistencies Under the 2016 HealthCare.gov Choice Architecture.

Wang AZ, Scherr KA, Wong CA, Ubel PA.

MDM Policy Pract. 2017 Jan-Jun;2(1). doi: 10.1177/2381468317716441. Epub 2017 Jun 28.

37.

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer.

Rose TL, Deal AM, Ladoire S, Créhange G, Galsky MD, Rosenberg JE, Bellmunt J, Wimalasingham A, Wong YN, Harshman LC, Chowdhury S, Niegisch G, Liontos M, Yu EY, Pal SK, Chen RC, Wang AZ, Nielsen ME, Smith AB, Milowsky MI; Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators.

Bladder Cancer. 2016 Oct 27;2(4):405-413. doi: 10.3233/BLC-160072.

38.

Co-delivery of all-trans-retinoic acid enhances the anti-metastasis effect of albumin-bound paclitaxel nanoparticles.

Huang H, Shi H, Liu J, Min Y, Wang Y, Wang AZ, Wang J, Liu Y.

Chem Commun (Camb). 2016 Dec 20;53(1):212-215.

PMID:
27918025
39.

Prostate deformation from inflatable rectal probe cover and dosimetric effects in prostate seed implant brachytherapy.

Lian J, Shao Y, Potter LD, Chen RC, Holmes JA, Pryser EA, Shen J, Shen D, Wang AZ.

Med Phys. 2016 Dec;43(12):6569.

40.

Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer.

Tian J, Min Y, Rodgers Z, Wan X, Qiu H, Mi Y, Tian X, Wagner KT, Caster JM, Qi Y, Roche K, Zhang T, Cheng J, Wang AZ.

Nanomedicine. 2017 Apr;13(3):1301-1307. doi: 10.1016/j.nano.2016.11.007. Epub 2016 Nov 21.

41.

A Combined Intervention of Zinc, Multiple Micronutrients, and Albendazole Does Not Ameliorate Environmental Enteric Dysfunction or Stunting in Rural Malawian Children in a Double-Blind Randomized Controlled Trial.

Wang AZ, Shulman RJ, Crocker AH, Thakwalakwa C, Maleta KM, Devaraj S, Manary MJ, Trehan I.

J Nutr. 2017 Jan;147(1):97-103. doi: 10.3945/jn.116.237735. Epub 2016 Nov 2.

PMID:
27807040
42.

CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α.

Tian X, Nguyen M, Foote HP, Caster JM, Roche KC, Peters CG, Wu P, Jayaraman L, Garmey EG, Tepper JE, Eliasof S, Wang AZ.

Cancer Res. 2017 Jan 1;77(1):112-122. doi: 10.1158/0008-5472.CAN-15-2951. Epub 2016 Oct 26. Erratum in: Cancer Res. 2017 Dec 1;77(23 ):6790-6791.

43.

Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody.

Wang C, Sun W, Wright G, Wang AZ, Gu Z.

Adv Mater. 2016 Oct;28(40):8912-8920. doi: 10.1002/adma.201506312. Epub 2016 Aug 25. Erratum in: Adv Mater. 2017 Apr;29(15):.

44.

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma.

Shao Z, Wang AZ, George DJ, Zhang T.

Asian J Urol. 2016 Oct;3(4):268-277. doi: 10.1016/j.ajur.2016.08.013. Epub 2016 Sep 6. Review.

45.

Preclinical Evaluation of Promitil, a Radiation-Responsive Liposomal Formulation of Mitomycin C Prodrug, in Chemoradiotherapy.

Tian X, Warner SB, Wagner KT, Caster JM, Zhang T, Ohana P, Gabizon AA, Wang AZ.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):547-55. doi: 10.1016/j.ijrobp.2016.06.2457. Epub 2016 Jul 1.

PMID:
27681751
46.

Angiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart Disease.

Lu Q, Yao Y, Hu Z, Hu C, Song Q, Ye J, Xu C, Wang AZ, Chen Q, Wang QK.

PLoS Biol. 2016 Aug 11;14(8):e1002529. doi: 10.1371/journal.pbio.1002529. eCollection 2016 Aug.

47.

Nanoparticle formulation of small DNA molecules, Dbait, improves the sensitivity of hormone-independent prostate cancer to radiotherapy.

Yao H, Qiu H, Shao Z, Wang G, Wang J, Yao Y, Xin Y, Zhou M, Wang AZ, Zhang L.

Nanomedicine. 2016 Nov;12(8):2261-2271. doi: 10.1016/j.nano.2016.06.010. Epub 2016 Jul 4.

PMID:
27389144
48.

Knowing so much, yet knowing so little: a scoping review of interventions that address the stigma of mental illness in the Canadian context.

Guruge S, Wang AZ, Jayasuriya-Illesinghe V, Sidani S.

Psychol Health Med. 2017 Jun;22(5):507-523. doi: 10.1080/13548506.2016.1191655. Epub 2016 Jun 4. Review.

PMID:
27264792
49.

Accurate Segmentation of CT Male Pelvic Organs via Regression-Based Deformable Models and Multi-Task Random Forests.

Gao Y, Shao Y, Lian J, Wang AZ, Chen RC, Shen D.

IEEE Trans Med Imaging. 2016 Jun;35(6):1532-43. doi: 10.1109/TMI.2016.2519264. Epub 2016 Jan 18.

50.

Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic.

Au KM, Satterlee A, Min Y, Tian X, Kim YS, Caster JM, Zhang L, Zhang T, Huang L, Wang AZ.

Biomaterials. 2016 Mar;82:178-93. doi: 10.1016/j.biomaterials.2015.12.018. Epub 2015 Dec 20.

Supplemental Content

Support Center